ArticlePsychiatry investigation2017

Efficacy and Safety of Bitopertin in Patients with Schizophrenia and Predominant Negative Symptoms: Subgroup Analysis of Japanese Patients from the Global Randomized Phase 2 Trial.

Yoshio Hirayasu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.